Clinical Scorecard: A New Route to Lymphoma Diagnosis

At a Glance

Key Highlights

• Liquid biopsy showed high diagnostic accuracy with sensitivity of 0.86 and specificity of 0.95.
• Median turnaround time for liquid biopsy was 6.5 days compared to 46.8 days for tissue biopsy.
• 42% of cases had liquid biopsy results available at the first multidisciplinary team review.
• Combining multiple molecular markers improved diagnostic accuracy.
• Liquid biopsy may complement tissue-based methods, especially in areas with limited histopathology services.

Guideline-Based Recommendations

Diagnosis

• Use liquid biopsy to support faster diagnosis of EBV-positive BL.
• Integrate multiple molecular markers for improved discrimination between BL and other conditions.

Management

• Consider blood-based testing to guide early clinical decisions.

Monitoring & Follow-up

• Monitor ctDNA levels and EBV DNA markers for disease progression.

Risks

• Implementation challenges include cost and access to sequencing infrastructure.

Patient & Prescribing Data

Children and young adults with suspected lymphoma.

Liquid biopsy may facilitate earlier diagnosis and treatment initiation.

Clinical Best Practices

• Utilize liquid biopsy as a complementary tool alongside tissue biopsy.
• Ensure further validation of liquid biopsy findings in broader populations.

Related Resources & Content